<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6790">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03018522</url>
  </required_header>
  <id_info>
    <org_study_id>AntalyaTRH14</org_study_id>
    <nct_id>NCT03018522</nct_id>
  </id_info>
  <brief_title>S100B Protein and Postoperative Cognitive Dysfunction</brief_title>
  <official_title>S100B Protein as Predictor of Cognitive Dysfunction After Robot-assisted Radical Prostatectomy: A Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Antalya Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Antalya Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary aim of this study is to evaluate the association between postoperative cognitive
      dysfunction and increased serum levels of S100B protein after robot-assisted laparoscopic
      radical prostatectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The neurocognitive assessment protocol will design to evaluate general cognitive function
      and identify patients with cognitive dysfunction. Neuropsychological tests of all patients
      will conduct on the one day prior to surgery, the first day after surgery, and the 30 th day
      after surgery, respectively. According to a consensus statement, cognitive function will
      assess using a battery of seven neuropsychological tests: Rey Auditory Verbal Learning Test
      (delayed recall), Trail Making Test (Parts A and B), Digit Span Test (forward and backward),
      and Grooved Pegboard Test (dominant and non-dominant hands). Postoperative cognitive
      dysfunction (POCD) was defined as a decline of &gt;20% from preoperative test scores in at
      least two of seven tests.

      Serum levels of S100B protein will obtain from venous blood samples collected before
      surgery, after the anesthesia induction, immediately after surgery and 24 h postoperatively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Score in Neuropsychological Tests</measure>
    <time_frame>Change from neuropsychological test scores at 30 days.</time_frame>
    <description>This assessment will be applied before surgery, and 1 and 30 days after surgery.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">69</enrollment>
  <condition>Postoperative Cognitive Dysfunction</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Postoperative cognitive dysfunction</intervention_name>
    <description>Neuropsychological tests of all patients will conduct on the one day prior to surgery, the first day after surgery, and the 30 th day after surgery</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults between 50 and 90 years of age with robot assisted laparoscopic radical
        prostatectomy , were selected in the study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  over 50 years old

          -  scheduled for robotic-assisted laparoscopic radical prostatectomy

          -  the body mass index ranged from 18 kg/m2 to 25 kg/m2

          -  American Society of Anesthesiologists class I, II or III

        Exclusion Criteria:

          -  Patients with previous neurological deficit (symptomatic stroke, hemorrhage,
             transient ischemic attack)

          -  other neurologic disorders (epilepsy, trauma, intra- or extracranial malignancy)

          -  psychiatric diseases (schizophrenia, or depressive disorder)

          -  alcoholism or any other drug dependence

          -  serious hearing or visual impairment
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nilgun Kavrut Ozturk, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Antalya Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Antalya Training and Research Hospital, Department of Anesthesiology and Reanimation</name>
      <address>
        <city>Antalya</city>
        <zip>07100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Silva FP, Schmidt AP, Valentin LS, Pinto KO, Zeferino SP, Oses JP, Wiener CD, Otsuki DA, Tort AB, Portela LV, Souza DO, Auler JO Jr, Carmona MJ. S100B protein and neuron-specific enolase as predictors of cognitive dysfunction after coronary artery bypass graft surgery: A prospective observational study. Eur J Anaesthesiol. 2016 Sep;33(9):681-9. doi: 10.1097/EJA.0000000000000450.</citation>
    <PMID>27433840</PMID>
  </reference>
  <reference>
    <citation>Tomaszewski D. Biomarkers of Brain Damage and Postoperative Cognitive Disorders in Orthopedic Patients: An Update. Biomed Res Int. 2015;2015:402959. doi: 10.1155/2015/402959. Epub 2015 Aug 31. Review.</citation>
    <PMID>26417595</PMID>
  </reference>
  <reference>
    <citation>Chen K, Wei P, Zheng Q, Zhou J, Li J. Neuroprotective effects of intravenous lidocaine on early postoperative cognitive dysfunction in elderly patients following spine surgery. Med Sci Monit. 2015 May 15;21:1402-7. doi: 10.12659/MSM.894384.</citation>
    <PMID>25975969</PMID>
  </reference>
  <reference>
    <citation>van Munster BC, Korevaar JC, Korse CM, Bonfrer JM, Zwinderman AH, de Rooij SE. Serum S100B in elderly patients with and without delirium. Int J Geriatr Psychiatry. 2010 Mar;25(3):234-9. doi: 10.1002/gps.2326.</citation>
    <PMID>19575407</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 23, 2017</lastchanged_date>
  <firstreceived_date>January 9, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
